Bromodomains in protozoan parasites: Evolution, function, and opportunities for drug development

Victoria Jeffers, Chunlin Yang, Sherri Huang, William Sullivan

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Parasitic infections remain one of the most pressing global health concerns of our day, affecting billions of people and producing unsustainable economic burdens. The rise of drug-resistant parasites has created an urgent need to study their biology in hopes of uncovering new potential drug targets. It has been established that disrupting gene expression by interfering with lysine acetylation is detrimental to survival of apicomplexan (Toxoplasma gondii and Plasmodium spp.) and kinetoplastid (Leishmania spp. and Trypanosoma spp.) parasites. As "readers" of lysine acetylation, bromodomain proteins have emerged as key gene expression regulators and a promising new class of drug target. Here we review recent studies that demonstrate the essential roles played by bromodomain-containing proteins in parasite viability, invasion, and stage switching and present work showing the efficacy of bromodomain inhibitors as novel antiparasitic agents. In addition, we performed a phylogenetic analysis of bromodomain proteins in representative pathogens, some of which possess unique features that may be specific to parasite processes and useful in future drug development.

Original languageEnglish (US)
Article numbere00047-16
JournalMicrobiology and Molecular Biology Reviews
Volume81
Issue number1
DOIs
StatePublished - Mar 1 2017

Fingerprint

Parasites
Acetylation
Pharmaceutical Preparations
Lysine
Trypanosoma
Gene Expression
Antiparasitic Agents
Parasitic Diseases
Proteins
Plasmodium
Leishmania
Toxoplasma
Economics

Keywords

  • Epigenetics
  • Leishmania
  • Malaria
  • Plasmodium
  • Toxoplasma
  • Trypanosomes

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology and Microbiology(all)

Cite this

Bromodomains in protozoan parasites : Evolution, function, and opportunities for drug development. / Jeffers, Victoria; Yang, Chunlin; Huang, Sherri; Sullivan, William.

In: Microbiology and Molecular Biology Reviews, Vol. 81, No. 1, e00047-16, 01.03.2017.

Research output: Contribution to journalReview article

@article{5f5396be1b0541acb4f39fce57ac5642,
title = "Bromodomains in protozoan parasites: Evolution, function, and opportunities for drug development",
abstract = "Parasitic infections remain one of the most pressing global health concerns of our day, affecting billions of people and producing unsustainable economic burdens. The rise of drug-resistant parasites has created an urgent need to study their biology in hopes of uncovering new potential drug targets. It has been established that disrupting gene expression by interfering with lysine acetylation is detrimental to survival of apicomplexan (Toxoplasma gondii and Plasmodium spp.) and kinetoplastid (Leishmania spp. and Trypanosoma spp.) parasites. As {"}readers{"} of lysine acetylation, bromodomain proteins have emerged as key gene expression regulators and a promising new class of drug target. Here we review recent studies that demonstrate the essential roles played by bromodomain-containing proteins in parasite viability, invasion, and stage switching and present work showing the efficacy of bromodomain inhibitors as novel antiparasitic agents. In addition, we performed a phylogenetic analysis of bromodomain proteins in representative pathogens, some of which possess unique features that may be specific to parasite processes and useful in future drug development.",
keywords = "Epigenetics, Leishmania, Malaria, Plasmodium, Toxoplasma, Trypanosomes",
author = "Victoria Jeffers and Chunlin Yang and Sherri Huang and William Sullivan",
year = "2017",
month = "3",
day = "1",
doi = "10.1128/MMBR.00047-16",
language = "English (US)",
volume = "81",
journal = "Microbiology and Molecular Biology Reviews",
issn = "1092-2172",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Bromodomains in protozoan parasites

T2 - Evolution, function, and opportunities for drug development

AU - Jeffers, Victoria

AU - Yang, Chunlin

AU - Huang, Sherri

AU - Sullivan, William

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Parasitic infections remain one of the most pressing global health concerns of our day, affecting billions of people and producing unsustainable economic burdens. The rise of drug-resistant parasites has created an urgent need to study their biology in hopes of uncovering new potential drug targets. It has been established that disrupting gene expression by interfering with lysine acetylation is detrimental to survival of apicomplexan (Toxoplasma gondii and Plasmodium spp.) and kinetoplastid (Leishmania spp. and Trypanosoma spp.) parasites. As "readers" of lysine acetylation, bromodomain proteins have emerged as key gene expression regulators and a promising new class of drug target. Here we review recent studies that demonstrate the essential roles played by bromodomain-containing proteins in parasite viability, invasion, and stage switching and present work showing the efficacy of bromodomain inhibitors as novel antiparasitic agents. In addition, we performed a phylogenetic analysis of bromodomain proteins in representative pathogens, some of which possess unique features that may be specific to parasite processes and useful in future drug development.

AB - Parasitic infections remain one of the most pressing global health concerns of our day, affecting billions of people and producing unsustainable economic burdens. The rise of drug-resistant parasites has created an urgent need to study their biology in hopes of uncovering new potential drug targets. It has been established that disrupting gene expression by interfering with lysine acetylation is detrimental to survival of apicomplexan (Toxoplasma gondii and Plasmodium spp.) and kinetoplastid (Leishmania spp. and Trypanosoma spp.) parasites. As "readers" of lysine acetylation, bromodomain proteins have emerged as key gene expression regulators and a promising new class of drug target. Here we review recent studies that demonstrate the essential roles played by bromodomain-containing proteins in parasite viability, invasion, and stage switching and present work showing the efficacy of bromodomain inhibitors as novel antiparasitic agents. In addition, we performed a phylogenetic analysis of bromodomain proteins in representative pathogens, some of which possess unique features that may be specific to parasite processes and useful in future drug development.

KW - Epigenetics

KW - Leishmania

KW - Malaria

KW - Plasmodium

KW - Toxoplasma

KW - Trypanosomes

UR - http://www.scopus.com/inward/record.url?scp=85011591285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011591285&partnerID=8YFLogxK

U2 - 10.1128/MMBR.00047-16

DO - 10.1128/MMBR.00047-16

M3 - Review article

C2 - 28077462

AN - SCOPUS:85011591285

VL - 81

JO - Microbiology and Molecular Biology Reviews

JF - Microbiology and Molecular Biology Reviews

SN - 1092-2172

IS - 1

M1 - e00047-16

ER -